CME

Treating Advanced Dry Age-related Macular Degeneration and Geographic Atrophy: Here and Now

Treating Advanced Dry Age-related Macular Degeneration and Geographic Atrophy: Here and Now

This activity is supported by an educational grant from Genentech, Inc.

Overview

Author(s)/Faculty: Michael S. Ip, MD; SriniVas R. Sadda, MD; Rishi P. Singh, MD
Source: Healio - Ophthalmology Education Lab
Type: LectureArticles/Items: 5
Release Date: 3/14/2017Expiration Date: 3/13/2018
Credit Type: CMENumber of Credits: 1
Cost: FreeProvider: Vindico Medical Education
Age-related macular degeneration (AMD) is a deterioration or breakdown of the eye's macula. At present, pharmacotherapy is available only for late neovascular AMD. The prospect of effective therapies in the near future, together with an increasing incidence of AMD in an aging population, has led to increased interest in early, accurate diagnosis and classification of AMD, as well as medications to effectively treat it. This educational program will address imaging techniques and technology, evidence for optimizing treatment regimens and visual aids, as well as the potential clinical utility of emerging treatments for advanced dry age-related macular degeneration and geographic atrophy.

CME Information

page 1 of 8